One proposed mechanism involved in MFS aorto-pathy is the function of FBN1 as a regulator of TGF-β (transforming growth factor β) bioavailability, whereby defective FBN1 production leads to heightened TGF-β signaling and eventual aortic dilatation and aneurysms in mice. Here, FBN1 is linked to aneurysm.